» Articles » PMID: 9918906

Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection

Overview
Journal Hepatology
Specialty Gastroenterology
Date 1999 Jan 27
PMID 9918906
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

While patients with liver disease are known to have a higher prevalence of glucose intolerance, preliminary studies suggest that hepatitis C virus (HCV) infection may be an additional risk factor for the development of diabetes mellitus. To further study the correlation of HCV infection and diabetes, we performed a retrospective analysis of 1,117 patients with chronic viral hepatitis and analyzed whether age, sex, race, hepatitis B virus (HBV) infection, HCV infection, and cirrhosis were independently associated with diabetes. In addition, a case-control study was conducted to determine the seroprevalence of HCV infection in a cohort of 594 diabetics and 377 clinic patients assessed for thyroid disease. In the former study after the exclusion of patients with conditions predisposing to hyperglycemia, diabetes was observed in 21% of HCV-infected patients compared with 12% of HBV-infected subjects (P =.0004). Multivariate analysis revealed that HCV infection (P =.02) and age (P =.01) were independent predictors of diabetes. In the diabetes cohort, 4.2% of patients were found to be infected with HCV compared with 1.6% of control patients (P =.02). HCV genotype 2a was observed in 29% of HCV-RNA-positive diabetic patients versus 3% of local HCV-infected controls (P <.005). In conclusion, the data suggest a relatively strong association between HCV infection and diabetes, because diabetics have an increased frequency of HCV infection, particularly with genotype 2a. Furthermore, it is possible that HCV infection may serve as an additional risk factor for the development of diabetes, beyond that attributable to chronic liver disease alone.

Citing Articles

Measures of insulin resistance and beta cell function before and after treatment of HCV infection.

Chen J, Qiu P, Zhao T, Jiang H, Tursun K, Ksimu S Virol Sin. 2024; 39(4):667-674.

PMID: 38950863 PMC: 11401464. DOI: 10.1016/j.virs.2024.06.007.


Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetes.

Cheng Y, Lee T, Li Y, Lu C, Liu H, Sheu M Sci Rep. 2024; 14(1):4607.

PMID: 38409227 PMC: 10897399. DOI: 10.1038/s41598-024-55352-7.


Discovering potential pathways between type 2 diabetes mellitus and diabetic retinopathy: A big data analysis of the South Korean National Sample Cohort.

Kim Y, Hyun C, Lee M Medicine (Baltimore). 2023; 102(31):e34576.

PMID: 37543803 PMC: 10402935. DOI: 10.1097/MD.0000000000034576.


Molecular Mechanisms Responsible for Diabetogenic Effects of COVID-19 Infection-Induction of Autoimmune Dysregulation and Metabolic Disturbances.

Grubisic B, Svitek L, Ormanac K, Sabo D, Mihaljevic I, Bilic-Curcic I Int J Mol Sci. 2023; 24(14).

PMID: 37511334 PMC: 10380525. DOI: 10.3390/ijms241411576.


Transcriptional Analysis of TP53 Gene in Chronic Hepatitis C Patients Treated with Sofosbuvir, Daclatasvir, Pegylated Interferon, and Ribavirin.

Chudhary H, Ali A, Bibi S, Waqas M, Rafique S, Idrees M ACS Omega. 2023; 8(16):14784-14791.

PMID: 37125127 PMC: 10134244. DOI: 10.1021/acsomega.3c00903.